Table I.
Expression level | ||||
---|---|---|---|---|
Clinical parameters | Cases (n) | miR-875-5phigh (n=45) | miR-875-5plow (n=45) | P-value |
Age (years) | 0.499 | |||
<50 | 29 | 16 | 13 | |
≥50 | 61 | 29 | 32 | |
Sex | 0.561 | |||
Male | 76 | 39 | 37 | |
Female | 14 | 6 | 8 | |
Tumor size (cm) | 0.006a | |||
<5 | 47 | 30 | 17 | |
≥5 | 43 | 15 | 28 | |
Tumor number | 0.267 | |||
Solitary | 59 | 33 | 26 | |
Multiple | 31 | 12 | 19 | |
TNM stage | 0.016a | |||
I+II | 72 | 41 | 31 | |
III+IV | 18 | 4 | 14 | |
Capsular infiltration | 0.255 | |||
Present | 62 | 34 | 28 | |
Absent | 28 | 11 | 17 | |
Venous infiltration | 0.033a | |||
Present | 38 | 14 | 24 | |
Absent | 52 | 31 | 21 | |
AFP (ng/ml) | 0.809 | |||
<20 | 23 | 12 | 11 | |
≥20 | 67 | 33 | 34 | |
HBsAg | 0.788 | |||
Positive | 73 | 36 | 37 | |
Negative | 17 | 9 | 8 |
P<0.05.